Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 22:12:761556.
doi: 10.3389/fphys.2021.761556. eCollection 2021.

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption

Daniel J Beard  1   2 , Gina Hadley  2 , Brad A Sutherland  3 , Alastair M Buchan  2
Affiliations
Comment

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption

Daniel J Beard et al. Front Physiol. .
No abstract available

Keywords: Rapalink-1; mTOR–mammalian target of rapamycin; neuroprotection; rapamycin; stroke.

PubMed Disclaimer

Conflict of interest statement

AB is a co-founder of Brainomix, a company that develops electronic ASPECTS (e-ASPECTS), an automated method to evaluate ASPECTS in stroke patients. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Arriola Apelo S. I., Neuman J. C., Baar E. L., Syed F. A., Cummings N. E., Brar H. K., et al. . (2016). Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell 15, 28–38. 10.1111/acel.12405 - DOI - PMC - PubMed
    1. Ashburn T. T., Thor K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673–683. 10.1038/nrd1468 - DOI - PubMed
    1. Beard D. J., Hadley G., Thurley N., Howells D. W., Sutherland B. A., Buchan A. M. (2019). The effect of rapamycin treatment on cerebral ischemia: a systematic review and meta-analysis of animal model studies. Int. J. Stroke 14, 137–145. 10.1177/1747493018816503 - DOI - PubMed
    1. Buckley K. M., Hess D. L., Sazonova I. Y., Periyasamy-Thandavan S., Barrett J. R., Kirks R., et al. . (2014). Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp. Transl. Stroke Med. 6:8. 10.1186/2040-7378-6-8 - DOI - PMC - PubMed
    1. Chi O., Liu X., Cofano S., Patel N., Jacinto E., Weiss H. (2021). Rapalink-1 increased infarct size in early cerebral ischemia–reperfusion with increased blood–brain barrier disruption. Front. Physiol. 12:706528. 10.3389/fphys.2021.706528 - DOI - PMC - PubMed